$ABIO ARCA biopharma, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARCA biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARCA biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ARCA biopharma, Inc. for free.
IRS Number: 363855489
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: ABIO
Company Address: 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER 80021
Phone number: 720-940-2200
Former name: HYSEQ INC, date of change: 1997-06-10
Former name: NUVELO INC, date of change: 2003-02-03
Market Capitalization: $23.40M
Prev close: $2.60
Average Daily Volume: 34,121
Days Low: $2.55
Year Low: $2.15
Year High: $4.35
ARCA biopharma, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 3.19 | 10,000 | 31,947 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Woosley Raymond L. | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Grais Linda | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Dec 23 2020 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 4.27 | 70,000 | 298,900 | 70,000 | |
| Dec 23 2020 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Option Exercise | A | 4.27 | 70,000 | 298,900 | 70,000 | |
| Dec 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.16 | 10,000 | 41,630 | 30,000 | 20 K to 30 K (+50.00 %) |
| Sep 25 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.28 | 5,000 | 21,400 | 20,000 | 15 K to 20 K (+33.33 %) |
| Sep 24 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.66 | 3,056 | 14,241 | 15,000 | 11.9 K to 15 K (+25.59 %) |
| Sep 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.77 | 10,000 | 47,660 | 11,944 | 1.9 K to 11.9 K (+514.40 %) |
| Apr 03 2018 | ABIO | ARCA biopharma, In ... | Keuer Thomas A | Chief Operating Off ... | Sell | S | 0.50 | 482 | 242 | 13,153 | 13.6 K to 13.2 K (-3.54 %) |
| Mar 05 2018 | ABIO | ARCA biopharma, In ... | MITCHELL DANIEL J | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 | |
| Mar 05 2018 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 |